Osamu Maeda

Title: Osamu Maeda: Innovator in Colorectal Cancer Research

Introduction

Osamu Maeda is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of cancer research, particularly in understanding the genetic factors associated with colorectal cancer. His work has implications for both detection and treatment of this prevalent disease.

Latest Patents

Maeda holds a patent titled "Aberrant methylation of C6Orf150 DNA sequences in human colorectal cancer." This application describes methods and compositions for detecting and treating C6Orf150-associated neoplasia. Differential methylation of the C6Orf150 nucleotide sequences has been observed in C6Orf150-associated neoplasia, such as colon neoplasia. He has 1 patent related to this important area of research.

Career Highlights

Throughout his career, Osamu Maeda has worked with prestigious institutions, including Case Western Reserve University and the University of Texas System. His research has focused on the molecular mechanisms underlying cancer, contributing to advancements in the field.

Collaborations

Maeda has collaborated with esteemed colleagues such as Sanford D. Markowitz and Helen Moinova. Their joint efforts have furthered the understanding of cancer biology and potential therapeutic approaches.

Conclusion

Osamu Maeda's innovative work in colorectal cancer research highlights the importance of genetic factors in disease detection and treatment. His contributions continue to influence the field and pave the way for future advancements.